NOV
45
2
APA
30
5
ADP
57
2
AZO
46
3
CHRW
53
2
MRK
25
2
SHW
42
5
GM
55
6
INTC
35
4
GIS
47
13
XRX
48
2
MS
64
3
PYPL
49
4
WFC
58
8
MCO
67
3
PNC
48
6
STX
34
2
NEE
39
9
CMA
42
3
CCL
68
6
NOV
45
2
APA
30
5
ADP
57
2
AZO
46
3
CHRW
53
2
MRK
25
2
SHW
42
5
GM
55
6
INTC
35
4
GIS
47
13
XRX
48
2
MS
64
3
PYPL
49
4
WFC
58
8
MCO
67
3
PNC
48
6
STX
34
2
NEE
39
9
CMA
42
3
CCL
68
6
Financhill
Back

Biomarin Pharmaceutical Vs. Nukkleus Industry Stock Comparison

Buy
60

BMRN
Biomarin Pharmaceutical

Last Price:
$65.65
Seasonality Move:
5.39%
Sell
46

NUKK
Nukkleus

Last Price:
$40.15
Seasonality Move:
-21.57%
Buy
60
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $65.69. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $40.00. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $65.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $40.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 48.8 Sell
Chaikin Money Flow: 1709604 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.56 - 66.54) Buy
Bollinger Bands (100): (64.13 - 84.07) Sell

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.69 Buy
Relative Strength Index (14 RSI): 77.28 Buy
Chaikin Money Flow: -1366926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-7.5 - 22.6) Buy
Bollinger Bands (100): (-4.22 - 11.5) Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.79 Sell
20-day SMA: 65.64 Buy
50-day SMA: 66.69 Sell
200-day SMA: 78.92 Sell
8-day EMA: 65.67 Buy
20-day EMA: 65.74 Sell
50-day EMA: 67.62 Sell
200-day EMA: 77.02 Sell

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.07 Buy
20-day SMA: 9 Buy
50-day SMA: 4.99 Buy
200-day SMA: 4.78 Buy
8-day EMA: 26.51 Buy
20-day EMA: 14.21 Buy
50-day EMA: 7.47 Buy
200-day EMA: 11.77 Buy

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.90 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):